Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Aurisco Pharmaceutical Co.,Ltd.
  6. Summary
    605116   CNE1000042S4

AURISCO PHARMACEUTICAL CO.,LTD.

(605116)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/30/2021 12/01/2021 12/02/2021 12/03/2021 12/06/2021 Date
21.53 19.38 17.57 16.9 16.69 Last
22599160 18622710 14936460 10617380 6787687 Volume
+10.02% -9.99% -9.34% -3.81% -1.24% Change
Estimated financial data (e)
Sales 2021 819 M 129 M 129 M
Net income 2021 185 M 29,1 M 29,1 M
Net Debt 2021 - - -
P/E ratio 2021 36,3x
Yield 2021 -
Sales 2022 902 M 142 M 142 M
Net income 2022 216 M 33,9 M 33,9 M
Net Debt 2022 - - -
P/E ratio 2022 30,9x
Yield 2022 -
Capitalization 6 693 M 1 050 M 1 051 M
Capi. / Sales 2021 8,17x
Capi. / Sales 2022 7,42x
Nbr of Employees 939
Free-Float 9,15%
More Financials
Company
Aurisco Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of specialty active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The Company's main products are respiratory, cardiovascular, anti-infective and nervous system drugs, including flumethasone, fluticasone propionate, eplerenone, tenofovir, pregabalin and other APIs and... 
Sector
Pharmaceuticals
Calendar
04/19Earnings Release
More about the company
All news about AURISCO PHARMACEUTICAL CO.,LTD.
10/29Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
09/21Certain A Shares of Aurisco Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement ..
CI
09/20AURISCO PHARMACEUTICAL CO.,LTD.(SHSE : 605116) added to Shanghai Stock Exchange A Share In..
CI
09/20AURISCO PHARMACEUTICAL CO.,LTD.(SHSE : 605116) added to Shanghai Stock Exchange Composite ..
CI
08/30Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 3..
CI
04/28Aurisco Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter Ended ..
CI
04/19Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
2020Yangzhou Aurisco Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 ..
CI
2020Aurisco Pharmaceutical Co.,Ltd. Announces Major Financial Indicators in 1St Three Quart..
CI
2020Aurisco Pharmaceutical Co.,Ltd. has completed an IPO in the amount of CNY 343.17 millio..
CI
2020Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
2019Aurisco Pharmaceutical Co.,Ltd. has filed an IPO.
CI
2019Aurisco Pharmaceutical Co.,Ltd. has withdrawn its IPO.
CI
2019Aurisco Pharmaceutical Co.,Ltd. has filed an IPO.
CI
More news
News in other languages on AURISCO PHARMACEUTICAL CO.,LTD.

- No features available -

More news
Chart AURISCO PHARMACEUTICAL CO.,LTD.
Duration : Period :
Aurisco Pharmaceutical Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 16,69 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Ding Jun Chu Chief Executive Officer & Director
Xiu Yu Wang Chief Financial Officer
Zhi An Peng Chairman
Ping Jin Chairman-Supervisory Board
De Fa Zhang Chief Engineer & Production Manager
Sector and Competitors
1st jan.Capi. (M$)
AURISCO PHARMACEUTICAL CO.,LTD.5.17%1 050
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
PFIZER, INC.44.09%288 950
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321